DE MICCO, ROSA
 Distribuzione geografica
Continente #
EU - Europa 4.629
NA - Nord America 2.365
AS - Asia 2.127
SA - Sud America 318
Continente sconosciuto - Info sul continente non disponibili 144
AF - Africa 39
OC - Oceania 1
Totale 9.623
Nazione #
RU - Federazione Russa 3.294
US - Stati Uniti d'America 2.270
SG - Singapore 753
IT - Italia 502
CN - Cina 443
IE - Irlanda 340
HK - Hong Kong 285
VN - Vietnam 276
BR - Brasile 268
DE - Germania 119
KR - Corea 116
GB - Regno Unito 113
JP - Giappone 81
FR - Francia 62
IN - India 62
CA - Canada 45
UA - Ucraina 44
SE - Svezia 28
TR - Turchia 28
FI - Finlandia 24
GR - Grecia 23
AR - Argentina 20
MX - Messico 17
NL - Olanda 16
AT - Austria 14
ZA - Sudafrica 14
ID - Indonesia 12
PL - Polonia 12
BD - Bangladesh 11
CZ - Repubblica Ceca 11
CO - Colombia 9
IQ - Iraq 9
UZ - Uzbekistan 9
CR - Costa Rica 8
MA - Marocco 8
JO - Giordania 7
PK - Pakistan 7
EC - Ecuador 6
GT - Guatemala 6
EE - Estonia 5
ES - Italia 5
PH - Filippine 5
RO - Romania 5
BE - Belgio 4
JM - Giamaica 4
KE - Kenya 4
PE - Perù 4
AZ - Azerbaigian 3
EG - Egitto 3
HN - Honduras 3
KZ - Kazakistan 3
LT - Lituania 3
TN - Tunisia 3
VE - Venezuela 3
CL - Cile 2
DK - Danimarca 2
DZ - Algeria 2
IL - Israele 2
LB - Libano 2
LK - Sri Lanka 2
NP - Nepal 2
PR - Porto Rico 2
PY - Paraguay 2
SA - Arabia Saudita 2
SC - Seychelles 2
SV - El Salvador 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CI - Costa d'Avorio 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
GP - Guadalupe 1
GY - Guiana 1
KW - Kuwait 1
LC - Santa Lucia 1
MY - Malesia 1
NG - Nigeria 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 9.481
Città #
Moscow 1.195
San Jose 393
Singapore 389
Dublin 340
Santa Clara 304
Hong Kong 281
Ashburn 260
Council Bluffs 176
Seoul 115
Hefei 98
Ho Chi Minh City 88
Naples 86
Jacksonville 76
New York 75
Hanoi 65
Beijing 59
Chandler 56
Milan 54
Bengaluru 44
Los Angeles 38
Princeton 37
Bremen 32
Roxbury 32
Munich 30
The Dalles 26
São Paulo 25
Dallas 23
Medford 23
Rome 22
Napoli 18
Da Nang 17
London 17
Caserta 14
Orem 13
Boardman 12
Cambridge 12
Frankfurt am Main 12
Haiphong 12
Phoenix 12
Wilmington 12
Helsinki 11
Montreal 11
Warsaw 11
Avella 10
Falkenstein 10
Istanbul 10
Memphis 10
Miano 10
Nuremberg 10
Reggio Emilia 10
Brno 9
Carrboro 9
Des Moines 9
North Bergen 9
Tashkent 9
Amsterdam 8
Aversa 8
Brooklyn 8
Kochi 8
Manchester 8
San Francisco 8
Afragola 7
Amman 7
Ann Arbor 7
Atlanta 7
Catania 7
Curitiba 7
Jinan 7
Johannesburg 7
Mexico City 7
Nanjing 7
Norwalk 7
Palermo 7
Toronto 7
Biên Hòa 6
Guatemala City 6
Houston 6
Hải Dương 6
Ninh Bình 6
Rio de Janeiro 6
Shanghai 6
Stockholm 6
Thái Bình 6
Tokyo 6
Turku 6
Vienna 6
Viterbo 6
Bologna 5
Boston 5
Brasília 5
Buffalo 5
Casoria 5
Denver 5
Hangzhou 5
Quận Ba 5
Trento 5
Woodbridge 5
Zhengzhou 5
Belo Horizonte 4
Bogotá 4
Totale 5.021
Nome #
A transient third cranial nerve palsy as presenting sign of spontaneous intracranial hypotension 196
Cognitive impairment is associated with Hoehn and Yahr stages in early, de novo Parkinson disease patients 191
Clinical correlations of microstructural changes in progressive supranuclear palsy 175
Cognitive and morphometric features of mild cognitive impairment reversion in early patients with Parkinson's disease 169
Advanced visual network and cerebellar hyperresponsiveness to trigeminal nociception in migraine with aura 165
Cognitive Networks Disarrangement in Patients With Migraine Predicts Cutaneous Allodynia 159
Resting-state network connectivity changes in drug-naive Parkinson's disease patients with probable REM sleep behavior disorder 157
Medical retrofitting design 157
Cortical thickness changes in patients with Parkinson's disease and impulse control disorders 152
Fatigue in Parkinson's disease: Italian validation of the Parkinson Fatigue Scale and the Fatigue Severity Scale using a Rasch analysis approach 151
Altered domain-specific striatal functional connectivity in patients with Parkinson's disease and urinary symptoms 150
Central pain processing in "drug-naïve" pain-free patients with Parkinson's disease 150
Arterial spin labeling MRI applied to migraine: current insights and future perspectives 148
Non-motor impairments affect walking kinematics in Parkinson disease patients: A cross-sectional study 147
Rhythm-specific modulation of the sensorimotor network in drug-naive patients with Parkinson's disease by levodopa. 146
Continuous intra jejunal infusion of levodopa-carbidopa intestinal gel by jejunal extension tube placement through percutaneous endoscopic gastrostomy for patients with advanced Parkinson's disease: a preliminary study 138
Olfactory loss and brain connectivity after COVID-19 136
Fatigue in Parkinson's disease: A systematic review and meta-analysis 134
Olfactory Loss and Brain Connectivity after COVID-19: Structural Follow-Up at One Year 133
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 133
Connectivity Correlates of Anxiety Symptoms in Drug-Naive Parkinson's Disease Patients 130
A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort 130
Comparing Essential Tremor with and without Soft Dystonic Signs and Tremor Combined with Dystonia: The TITAN Study 129
Effectiveness and safety of an atropine/midazolam and target controlled infusion propofol-based moderate sedation protocol during percutaneous endoscopic transgastric jejunostomy procedures in Parkinson’s disease: a real-life retrospective observational study 125
Functional connectivity underpinnings of fatigue in "Drug-Naïve" patients with Parkinson's disease 125
Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease 125
Resting-State Functional MRI Approaches to Parkinsonisms and Related Dementia 124
A Novel Compound Heterozygous Mutation in Aprataxin Causes Slowly Progressive Ataxia without Oculomotor Apraxia 124
Correlates of the discrepancy between objective and subjective cognitive functioning in non-demented patients with Parkinson’s disease 121
Spinocerebellar ataxia 27B: a frequent and slowly progressive autosomal-dominant cerebellar ataxia—experience from an Italian cohort 120
Correction to: Spinocerebellar ataxia 27B: a frequent and slowly progressive autosomal-dominant cerebellar ataxia—experience from an Italian cohort 120
Galcanezumab effect on "whole pain burden" and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience 120
Memory Phenotypes In Early, De Novo Parkinson's Disease Patients with Mild Cognitive Impairment 119
Effects of safinamide on non-motor, cognitive, and behavioral symptoms in fluctuating Parkinson's disease patients: a prospective longitudinal study 119
Cerebro-cerebellar motor networks in clinical subtypes of Parkinson's disease 118
Brain Networks and Cognitive Impairment in Parkinson's Disease 118
Intrinsic brain connectivity predicts impulse control disorders in patients with Parkinson's disease 115
Intrinsic brain functional connectivity predicts treatment-related motor complications in early Parkinson’s disease patients 114
Validation of new diagnostic criteria for fatigue in patients with Parkinson disease 113
Motor, behavioural, and cognitive correlates of fatigue in early, de novo Parkinson disease patients 113
Resting-state brain networks in patients with Parkinson's disease and impulse control disorders 112
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 106
Correlates of psychological distress in epileptic patients during the COVID-19 outbreak 106
Multidisciplinary care use in neurodegenerative complex diseases: The example of progressive supranuclear palsy and advanced Parkinson's disease in real-life 105
Predictors of fatigue severity in early, de novo Parkinson disease patients: A 1-year longitudinal study 105
Sex-related pattern of intrinsic brain connectivity in drug-naïve Parkinson's disease patients 102
The psychological correlates of fatigue in Parkinson's disease: Contribution of maladaptive metacognitive beliefs 100
Kufor Rakeb syndrome without gaze palsy and pyramidal signs due to novel ATP13A2 mutations 100
Early classification of functional connectomes in Parkinson’s disease: a comparison of machine learning classifiers using multi-scale topological features 98
Fading of brain network fingerprint in Parkinson's disease predicts motor clinical impairment 98
Clinical correlates of “pure” essential tremor: the TITAN study 96
Supplementary motor area functional connectivity in “drug-naïve” Parkinson’s disease patients with fatigue 96
Skin Biopsy May Help to Distinguish Multiple System Atrophy-Parkinsonism from Parkinson's Disease With Orthostatic Hypotension 96
HPDL Biallelic Variants in Cerebral Palsy and Childhood‐Onset Hereditary Spastic Paraplegia: Human and Zebrafish Insights 95
Can we predict development of impulsive–compulsive behaviours in Parkinson’s disease? 95
Speech Rhythm Variation in Early-Stage Parkinson's Disease: A Study on Different Speaking Tasks 95
Flexible brain dynamics underpins complex behaviours as observed in Parkinson's disease 94
Subjective memory decline in Parkinson's disease patients with and without fatigue 94
SCAR32: Functional characterization and expansion of the clinical‐genetic spectrum 93
Validation of the Italian version of the PSP Quality of Life questionnaire 91
Structural MRI in Idiopathic Parkinson's Disease 90
Family History in Parkinson's Disease: A National Cross‐Sectional Study 87
Correlates of Psychological Distress in Patients with Parkinson's Disease During the COVID-19 Outbreak 87
The Italian tremor Network (TITAN): rationale, design and preliminary findings 86
Functional Connectivity Signatures of Parkinson's Disease 86
A Short Version of Carers' Quality of Life Questionnaire for Parkinsonism: Data from Progressive Supranuclear Palsy Network 84
A Short Progressive Supranuclear Palsy Quality of Life Scale: Data from the PSP‐NET 82
Pain and fatigue in Parkinson's disease: advances in diagnosis and management 81
Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson's disease 81
Analyzing Information Exchange in Parkinson’s Disease via Eigenvector Centrality: A Source-Level Magnetoencephalography Study 76
Levodopa Equivalent Dose of Safinamide: A Multicenter, Longitudinal, Case–Control Study 76
Distinctive Handwriting Signs in Early Parkinson’s Disease 76
Clinical trial eligibility in PSP: Population representativeness and potential criteria adjustment based on PSP-NET findings 76
Functional motor disorders associated with other neurological diseases: Beyond the boundaries of "organic" neurology 75
Impulse control behaviors in Parkinson's disease: Drugs or disease? Contribution from imaging studies 75
Editorial: Non-motor Symptoms in Primary Motor Neurological Disorders: From Molecular Pathways to Clinical and Therapeutic Implications 73
Molecular Imaging Markers to Track Huntington’s Disease Pathology 73
Characterising alexithymia in individuals with functional motor disorders: a cross-sectional analysis of the Italian Registry of Functional Motor Disorders 73
Functional motor phenotypes: to lump or to split? 73
Levodopa-carbidopa intrajejunal infusion in Parkinson's disease: untangling the role of age 73
Functional Connectomics and Disease Progression in Drug-Naïve Parkinson's Disease Patients 72
REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease 71
Functional Changes of the Perigenual Part of the Anterior Cingulate Cortex after External Trigeminal Neurostimulation in Migraine Patients 68
Effects of GBA1 Variants in Patients With Parkinson's Disease and Levodopa–Carbidopa Intestinal Gel: A Nation‐Wide, Multicenter, Longitudinal, “Real‐World” Study. The EPIC Study 64
Psychometric properties and clinical correlates of the Frontal Behaviour Inventory in progressive supranuclear palsy: data from the PSP-NET 56
LC-MS/MS-Based Determination of Ambroxol in Human Plasma and Cerebrospinal Fluid: Validation and Applicability in a Phase II Study on GBA-Associated Parkinson’s Disease Patients 56
Gender Is the Main Predictor of Wearing‐Off and Dyskinesia in Levodopa‐Naïve Patients with Parkinson's Disease 50
The Complex Pathway of Conventional Investigations before the Diagnosis of Functional Motor Disorders 48
Sex-related differences in striatal functional connectivity in early Parkinson’s disease 29
From mild cognitive impairment to normal cognition in Parkinson's disease: The role of brain network architecture 23
Exploring brain correlates of muscular activity and postural sway 17
Totale 9.623
Categoria #
all - tutte 31.539
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.539


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022225 0 0 0 10 70 4 6 8 13 21 25 68
2022/2023483 43 8 6 23 53 19 2 13 292 13 5 6
2023/2024374 28 16 18 17 110 79 9 5 1 8 27 56
2024/20251.233 8 28 7 29 226 181 169 132 162 103 91 97
2025/20265.851 244 392 250 291 448 3.079 341 227 210 211 104 54
2026/20271.020 49 84 428 459 0 0 0 0 0 0 0 0
Totale 9.623